RareCyte

RareCyte Completes $30M Private Financing

The firm plans to use the funding to expand commercial sales efforts, advance CDx partnerships, build its regulatory infrastructure, and explore new R&D avenues.

Breaking News

Barclays Initiates Coverage of Guardant Health, Exact Sciences, Natera With Overweight Rating
Early-Stage Firm PinkDx Closes $45M Upsized Series A Financing Round
Roche Gets 510(k) Clearance, CLIA Waiver for Liat Triplex Point-of-Care STI Test
Beckman Coulter, IU School of Medicine Win $2.5M NCI Grant to Expand Blood Cancer Testing in Kenya
Abbott Q4 Diagnostics Revenues up 4 Percent, Excluding COVID-19 Tests
MRC Holland Gains IVDR Certification for Spinal Muscular Atrophy Newborn Screening Test

RareCyte

RareCyte Completes $30M Private Financing

Barclays Initiates Coverage of Guardant Health, Exact Sciences, Natera With Overweight Rating

Early-Stage Firm PinkDx Closes $45M Upsized Series A Financing Round

Roche Gets 510(k) Clearance, CLIA Waiver for Liat Triplex Point-of-Care STI Test

Beckman Coulter, IU School of Medicine Win $2.5M NCI Grant to Expand Blood Cancer Testing in Kenya

Abbott Q4 Diagnostics Revenues up 4 Percent, Excluding COVID-19 Tests

MRC Holland Gains IVDR Certification for Spinal Muscular Atrophy Newborn Screening Test